or Try an Advanced Search...

    Technical Analysis for XFOR - X4 Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.59 0.93% 0.01
    XFOR closed up 1.62 percent on Monday, July 1, 2024, on 1.37 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical XFOR trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction -0.68%
    Lower Bollinger Band Walk Weakness -0.68%
    Inside Day Range Contraction -0.68%
    Wide Bands Range Expansion -0.68%
    Gapped Up Strength -0.68%
    Below Lower BB Weakness -0.68%
    Oversold Stochastic Weakness -0.68%
    New 52 Week Closing Low Bearish 0.93%
    Volume Surge Other 0.93%
    New 52 Week Low Weakness 0.93%
    Older End-of-Day Signals for XFOR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Rose Above Lower Bollinger Band about 9 hours ago
    Up 10% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XFOR Chart by TradingView
    Basic chart:

    Profile

    X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Rare Diseases Small Molecule Treatment Of Rare Diseases

    Is XFOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 X4 slips after mid-stage data for lead drug in neutropenia
    Jun 27 X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial
    Jun 24 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
    Jun 3 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    May 29 X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
    May 13 X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    May 9 X4 Pharma gains on new $125 financing
    May 9 X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
    May 8 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
    May 8 XFOR: Data from Phase 2 CN Trial Expected in June 2024…
    See more XFOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.06
    52 Week Low 0.57
    Average Volume 3,125,419
    200-Day Moving Average 0.95
    50-Day Moving Average 1.02
    20-Day Moving Average 0.96
    10-Day Moving Average 0.87
    Average True Range 0.10
    RSI (14) 25.37
    ADX 18.61
    +DI 10.01
    -DI 34.51
    Chandelier Exit (Long, 3 ATRs) 0.84
    Chandelier Exit (Short, 3 ATRs) 0.86
    Upper Bollinger Bands 1.26
    Lower Bollinger Band 0.66
    Percent B (%b) -0.11
    BandWidth 63.20
    MACD Line -0.08
    MACD Signal Line -0.04
    MACD Histogram -0.0461
    Fundamentals Value
    Market Cap 98.6 Million
    Num Shares 167 Million
    EPS -0.68
    Price-to-Earnings (P/E) Ratio -0.87
    Price-to-Sales 53.87
    Price-to-Book 2.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.70
    Resistance 3 (R3) 0.70 0.67 0.68
    Resistance 2 (R2) 0.67 0.65 0.67 0.67
    Resistance 1 (R1) 0.63 0.63 0.62 0.62 0.67
    Pivot Point 0.60 0.60 0.60 0.60 0.60
    Support 1 (S1) 0.56 0.58 0.55 0.55 0.51
    Support 2 (S2) 0.53 0.56 0.53 0.51
    Support 3 (S3) 0.49 0.53 0.50
    Support 4 (S4) 0.48